Subscriptions
Expert Review of Anticancer Therapy
Impact Factor: 2.493
Indexed on MEDLINE & EMBASE
ISSN: 1473-7140
Volume: Number 11 (2011)
Frequency: 12 issues per year
“Expert Review of Anticancer Therapy gives readable, in-depth commentary about new and developing treatments in cancer that is timely and helpful.”
Dr Marshall R Posner, Associate Professor of Medicine, Harvard Medical School, Dana–Farber Cancer Institute, USA
Description:
Expert Review of Anticancer Therapy provides expert analysis and commentary on the performance of new therapeutic and diagnostic modalities in this new era for oncology.
Areas covered include:
• Therapeutic overviews of specific cancers
• Performance and benefits of newly approved anticancer agents
• New therapeutic indications
• Adverse effects – occurrence and reduction
• Prospects for medicines in late-stage trials approaching regulatory approval
• Combined approaches of chemotherapy and radiotherapy
• Epidemiologic studies highlighting prospects for cancer prevention and control
• New diagnostic approaches to screening and patient stratification
Expert Review of Anticancer Therapy provides a centralized resource of commentary and debate to inform clinical and economic decision-making in healthcare delivery.
Citations: MEDLINE/Index Medicus, EMBASE/Excerpta Medica, Chemical Abstracts, Science Citation Index Expanded™ (SciSearch®), Current Contents®/Clinical Medicine, Journal Citation Reports/Science Edition®, Index to Scientific Reviews®, Scopus
For more detailed information please click here.
Quote:
ISSN: 1473-7140